WallStSmart
QDEL

Quidel Corporation

NASDAQ: QDEL · HEALTHCARE · MEDICAL DEVICES

$11.49
-4.41% today

Updated 2026-04-29

Market cap
$782.42M
P/E ratio
P/S ratio
0.29x
EPS (TTM)
$-16.69
Dividend yield
52W range
$11 – $39
Volume
2.1M

Quidel Corporation (QDEL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+25.2%
Last 4 quarters
Revenue YoY growth
+2.2%
Most recent quarter
EPS YoY growth
-27.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-15.7%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-25.6%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-11$0.46-9.8%$29.21$23.74-18.7%
2025-11-06$0.80+60.0%$27.37$20.35-25.6%
2025-08-05$0.12+1100.0%$24.11$23.44-2.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.51$0.46-9.8%$723.60M+2.2%
2025-09-30$0.50$0.80+60.0%$699.90M-3.7%
2025-06-30$0.01$0.12+1100.0%$613.90M-3.6%
2025-03-31$0.59$0.74+25.4%$692.80M-2.6%
2024-12-31$0.58$0.63+8.6%$707.80M-4.7%
2024-09-30$0.32$0.85+165.6%$727.10M-2.3%
2024-06-30$-0.23$-0.07+69.6%$637.00M-4.2%
2024-03-31$0.39$0.44+12.8%$711.00M
2023-12-31$2.05$1.17-42.9%$742.60M
2023-09-30$0.60$0.90+50.0%$744.00M
2023-06-30$0.28$0.26-7.1%$665.10M

Frequently asked questions

Has Quidel Corporation beaten earnings estimates?
Quidel Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +25.2% over the last 3 quarters.
How does QDEL stock react to earnings?
QDEL stock has moved an average of -15.7% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Quidel Corporation's revenue growth rate?
Quidel Corporation reported year-over-year revenue growth of +2.2% in its most recent quarter, with EPS growing -27.0% year-over-year.